Medicinal chemistry and bioinformatics - Current trends in drugs discovery with networks topological indices

Current Topics in Medicinal Chemistry

Volumn 7, Issue 10, 2007, Pages 1015-1029

  González Díaz, Humberto ^a   Vilar, Santiago ^a   Santana, Lourdes ^a   Uriarte, Eugenio ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Chirality; DNA sequences representation; Markov model; Protein interaction networks; Proteomic maps; QSAR; Quantitative structure binding relationships; Topographic indices; Topological indices

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; BIOINFORMATICS; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; CHIRALITY; DATA BASE; DATA MINING; DNA SEQUENCE; DRUG DESIGN; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RESEARCH; INFORMATION RETRIEVAL; ISOMERISM; MATHEMATICAL COMPUTING; PROBABILITY; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEOMICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; VIRTUAL REALITY;

CHEMISTRY, PHARMACEUTICAL; COMPUTATIONAL BIOLOGY; DRUG DESIGN; LIGANDS; MODELS, CHEMICAL; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34447254270     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802607780906771     Document Type: Review

References (134)

1. Balaban, A.T.; Basak, S.C.; Beteringhe, A.; Mills, D., Supuran, C.T. QSAR study using topological indices for inhibition of carbonic anhydrase II by sulfanilamides and Schiff bases. Mol. Divers. 2004, 8, 401-412.
2. Abraham, M.H.; Kumarsingh, R.; Cometto-Muniz, J.E.; Cain, W.S. Draize eye scores and eye irritation thresholds in man can be combined into one QSAR. Ann. N. Y. Acad. Sci. 1998, 855, 652-656.
3. Agrawal, V.K.; Bano, S.; Khadikar, P.V. Topological approach to quantifying molecular lipophilicity of heterogeneous set of organic compounds. Bioorg. Med. Chem. 2003, 11, 4039-4047.
4. Barratt, M.D. Integrating computer prediction systems with in vitro methods towards a better understanding of toxicology. Toxicol. Lett. 1998, 102-103, 617-621.
5. Benigni, R.; Andreoli, C.; Giuliani, A. QSAR models for both mutagenic potency and activity: application to nitroarenes and aromatic amines. Environ. Mol. Mutagen. 1994, 24, 208-219.
6. Garcia-Garcia, A.; Galvez, J.; de Julian-Ortiz, J.V.; Garcia-Domenech, R.; Munoz, C.; Guna, R.; Borras, R. Search of chemical scaffolds for novel antituberculosis agents. J. Biomol. Screen. 2005, 10, 206-214.
7. Katritzky, A.R.; Gordeeva, E.V. Traditional topological indices vs electronic, geometrical, and combined molecular descriptors in QSAR/QSPR research. J. Chem. Inf. Comput. Sci. 1993, 33, 835-857.
8. Todeschini, R.; Consonni, V. Handbook of Molecular Descriptors, Wiley-VCH: Weinheim, Germany, 2002.
9. Estrada, E. Generalization of topological indices. Chem. Phys. Lett. 2001, 336, 248-252.
10. Gonzalez-Diaz, H.; Cruz-Monteagudo, M.; Viña, D.; Santana, L.; Uriarte, E.; De Clercq, E. QSAR for anti-RNA-virus activity, synthesis, and assay of anti-RSV carbonucleosides given a unified representation of spectral moments, quadratic, and topologic indices. Bioorg. Med. Chem. Lett. 2005, 15, 1651-1657.
11. Marrero-Ponce, Y.; Medina-Marrero, R.; Torrens, F.; Martinez, Y.; Romero-Zaldivar, V.; Castro, E.A. Atom, atom-type, and total nonstochastic and stochastic quadratic fingerprints: a promising approach for modeling of antibacterial activity. Bioorg. Med. Chem. 2005, 13, 2881-2899.
12. Marrero-Ponce, Y.; Montero-Torres, A.; Zaldivar, C.R.; Veitia, M.I.; Perez, M.M.; Sanchez, R.N. Non-stochastic and stochastic linear indices of the 'molecular pseudograph's atom adjacency matrix': application to 'in silico' studies for the rational discovery of new antimalarial compounds. Bioorg. Med. Chem. 2005, 13, 1293-1304.
13. Estrada, E.; Uriarte, E. Recent advances on the role of topological indices in drug discovery research. Curr. Med. Chem. 2001, 8, 1573-1588.
14. Seri-Levy, A.; West, S.; Richards, W.G. Molecular similarity, quantitative chirality, and QSAR for chiral drugs. J. Med. Chem. 1994, 37, 1727-1732.
15. Vilar, S.; Estrada, E.; Uriarte, E.; Santana, L.; Gutierrez, Y. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives. J. Chem. Inf. Model. 2005, 45, 502-514.
16. Vilar, S.; Santana, L.; Uriarte, E. Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action. J. Med. Chem. 2006, 49, 1118-1124.
17. Estrada, E.; Vilar, S.; Uriarte, E.; Gutierrez, Y. In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives. J. Chem. Inf. Comput. Sci. 2002, 42, 1194-1203.
18. Honorio, K.M.; Garratt, R.C.; Andricopulo, A.D. Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators. Bioorg. Med. Chem. Lett. 2005, 15, 3119-3125.
19. Golbraikh, A.; Bonchev, D.; Tropsha, A. Novel ZE-isomerism descriptors derived from molecular topology and their application to QSAR analysis. J. Chem. Inf. Comput. Sci. 2002, 42, 769-787.
20. Randić M. On characterization of molecular attributes. Acta Chim. Slov. 1998, 45, 239-252.
21. de Julián-Ortiz, J.V.; de Gregorio Alapont, C.; Rios-Santamarina, I.; Garcia-Doménech, R.; Gálvez, J. Prediction of properties of chiral compounds by molecular topology. J. Mol. Graph. Model. 1998, 16, 14-18.
22. Golbraikh, A.; Tropsha A. QSAR modeling using chirality descriptors derived from molecular topology. J. Chem. Inf. Comput. Sci. 2003, 43, 144-154.
23. Gonzalez-Diaz, H.; Sanchez, I.H.; Uriarte, E.; Santana, L. Symmetry considerations in Markovian chemicals 'in silico' design (MARCH-INSIDE) I: central chirality codification, classification of ACE inhibitors and prediction of sigma-receptor antagonist activities. Comput. Biol. Chem. 2003, 27, 217-227.
24. Gonzalez-Diaz, H.; Marrero, Y.; Hernandez, I.; Bastida, I.; Tenorio, E.; Nasco, O.; Uriarte, E.; Castanedo, N.; Cabrera, M.A.; Aguila, E.; Marrero, O.; Morales, A.; Perez, M. 3D-MEDNEs: an alternative "in silico" technique for chemical research in toxicology. 1. Prediction of chemically induced agramulocytosis. Chem. Res. Toxicol. 2003, 16, 1318-1327.
25. Gonzalez-Diaz, H.; Bastida, I.; Castanedo, N.; Nasco, O.; Olazabal, E.; Morales, A.; Serrano, H.S.; de Armas, R.R. Simple stochastic fingerprints towards mathematical modelling in biology and medicine. 1. The treatment of coccidiosis. Bull. Math. Biol. 2004, 66, 1285-1311.
26. Marrero-Ponce, Y.; Diaz, H.G.; Zaldivar, V.R.; Torrens, F.; Castro, E.A. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities. Bioorg. Med. Chem. 2004, 12, 5331-5342.
27. Castillo-Garit, J.A.; Marrero-Ponce, Y.; Torrens, F. Atom-based 3D-chiral quadratic indices. Part 2: Prediction of the corticosteroid-binding globulin binding affinity of the 31 benchmark steroids data set. Bioorg. Med. Chem. 2006, 14, 2398-2408.
28. Marrero-Ponce, Y.; Castillo-Garit, J.A. 3D-chiral atom, atom-type, and total non-stochastic and stochastic molecular linear indices and their applications to central chirality codification. J. Comput. Aided Mol. Des. 2005, 19, 369-383.
29. Lukovits, I.; Linert, L. A topological account of chirality. J. Chem. Inf. Comput. Sci. 2001, 41, 1517-1520.
30. Estrada, E.; Delgado, E.J.; Alderete, J.B.; Jana, G.A. Quantum-connectivity descriptors in modeling solubility of environmentally important organic compounds. J. Comput. Chem. 2004, 25, 1787-1796.
31. Estrada, E.; Molina, E. 3D connectivity indices in QSPR/QSAR studies. J. Chem. Inf. Comput. Sci. 2001, 41, 791-797.
32. Gozalbes, R.; Doucet, J.P.; Derouin, F. Application of topological descriptors in QSAR and drug design: history and new trends. Curr. Drug Targets Infect. Disord. 2002, 2, 93-102.
33. Carrasco-Velar, R.; Padron, J.A.; Galvez, J. Definition of a novel atomic index for QSAR: the refractotopological state. J. Pharm. Pharm. Sci. 2004, 7, 19-26.
34. Estrada, E.; Gonzalez-Diaz, H. What are the limits of applicability for graph theoretic descriptors in QSPR/QSAR? Modeling dipole moments of aromatic compounds with TOPS-MODE descriptors. J. Chem. Inf. Comput. Sci. 2003, 43, 75-84.
35. Estrada, E. On the topological sub-structural molecular design (TOSS-MODE) in QSPR/QSAR and drug design research. SAR QSAR Environ. Res. 2000, 11, 55-73.
36. Duchowicz, P.R.; Castro, E.A.; Toropov, A.A.; Nesterov, I.V.; Nabiev, O.M. QSPR modeling the aqueous solubility of alcohols by optimization of correlation weights of local graph invariants. Mol. Divers. 2004, 8, 325-330.
37. Duchowicz, P.; Castro, E.A.; Toropov, A.A. Improved QSPR analysis of standard entropy of acyclic and aromatic compounds using optimized correlation weights of linear graph invariants. Comput. Chem. 2002, 26, 327-332.
38. Matamala, A.R.; Estrada, E. Simplex optimization of generalized topological index (GTI-Simplex): A unified approach to optimize QSPR models. J. Phys. Chem. A Mol. Spectrosc. Kinet. Environ. Gen. Theory 2005, 109, 9890-9895.
39. Matamala, A.R.; Estrada, E. Generalised topological indices: Optimisation methodology and physico-chemical interpretation. Chem. Phys. Lett. 2005, 410, 343-347.
40. Gonzalez-Diaz, H.; Cruz-Monteagudo, M.; Molina, R.; Tenorio, E.; Uriarte, E. Predicting multiple drugs side effects with a general drug-target interaction thermodynamic Markov model. Bioorg. Med. Chem. 2005, 13, 1119-1129.
41. Gonzalez-Diaz, H.; Aguero, G.; Cabrera, M.A.; Molina, R.; Santana, L.; Uriarte, E.; Delogu, G.; Castanedo, N. Unified Markov thermodynamics based on stochastic forms to classify drugs considering molecular structure, partition system, and biological species: distribution of the antimicrobial G1 on rat tissues. Bioorg. Med. Chem. Lett. 2005, 15, 551-557.
42. Gonzalez-Diaz, H.; Prado-Prado, F.J.; Santana, L.; Uriarte, E. Unify QSAR approach to antimicrobials. Part 1: Predicting antifungal activity against different species. Bioorg. Med. Chem. 2006, 14, 5973-5980.
43. Marrero-Ponce, Y.; Marrero, R.M.; Torrens, F.; Martinez, Y.; Bernal, M.G.; Zaldivar, V.R.; Castro, E.A.; Abalo, R.G. Non-stochastic and stochastic linear indices of the molecular pseudograph's atom-adjacency matrix: a novel approach for computational in silico screening and "rational" selection of new lead antibacterial agents. J. Mol. Model. 2006, 12, 255-271.
44. Gonzalez-Diaz, H.; Torres-Gomez, L.A.; Guevara, Y.; Almeida, M.S.; Molina, R.; Castanedo, N.; Santana, L.; Uriarte, E. Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials. J. Mol. Model. (Online) 2005, 11, 116-123.
45. Garcia-Garcia, A.; Galvez, J.; de Julian-Ortiz, J.V.; Garcia-Domenech, R.; Munoz, C.; Guna, R.; Borras, R. New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. J. Antimicrob. Chemother. 2004, 53, 65-73.
46. Gozalbes, R.; Galvez, J.; Garcia-Domenech, R.; Derouin, F. Molecular search of new active drugs against Toxoplasma gondii. SAR QSAR Environ. Res. 1999, 10, 47-60.
47. Chalk, A.J.; Worth, C.L.; Overington, J.P.; Chan, A.W. PDBLIG: classification of small molecular protein binding in the Protein Data Bank. J. Med. Chem. 2004, 47, 3807-3816.
48. Deng, W.; Breneman, C.; Embrechts, M.J. Predicting protein-ligand binding affinities using novel geometrical descriptors and machine-learning methods. J. Chem. Inf. Comput. Sci. 2004, 44, 699-703.
49. Zhang, S.; Golbraikh, A.; Tropsha, A. Development of quantitative structure-binding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces. J. Med. Chem. 2006, 49, 2713-2724.
50. Estrada, E. Application of a novel graph-theoretic folding degree index to the study of steroid-DB3 antibody binding affinity. Comput. Biol. Chem. 2003, 27, 305-313.
51. Estrada, E. Characterization of the folding degree of proteins. Bioinformatics 2002, 18, 697-704.
52. Estrada, E.; Uriarte, E.; Vilar, S. Effect of protein backbone folding on the stability of protein-ligand complexes. J. Proteome Res. 2006, 5, 105-111.
53. Varani, L.; Spillantini, M.G.; Goedert, M.; Varani, G. Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics. Nucleic Acids Res. 2000, 28, 710-719.
54. Patel, D.J.; Suri, A.K. Structure, recognition and discrimination in RNA aptamer complexes with cofactors, amino acids, drugs and aminoglycoside antibiotics. J. Biotechnol. 2000, 74, 39-60.
55. Leclerc, F.; Cedergren, R. Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex. J. Med. Chem. 1998, 41, 175-182.
56. Zuker, M. Prediction of RNA secondary structure by energy minimization. Methods Mol. Biol. 1994, 25, 267-294.
57. Kim, N.; Shiffeldrim, N.; Gan, H.H.; Schlick, T. Candidates for novel RNA topologies. J. Mol. Biol. 2004, 341, 1129-1144.
58. Gonzalez-Diaz, H.; Aguero-Chapin, G.; Varona-Santos, J.; Molina, R.; de la Riva, G.; Uriarte, E. 2D RNA-QSAR: assigning ACC oxidase family membership with stochastic molecular descriptors; isolation and prediction of a sequence from Psidium guajava L. Bioorg. Med. Chem. Lett. 2005, 15, 2932-2937.
59. Gonzalez-Diaz, H.; de Armas, R.R.; Molina, R. Markovian negentropies in bioinformatics. 1. A picture of footprints after the interaction of the HIV-1 Psi-RNA packaging region with drugs. Bioinformatics 2003, 19, 2079-2087.
60. Gonzalez-Diaz, H.; de Armas, R.R.; Molina, R. Vibrational Markovian modelling of footprints after the interaction of antibiotics with the packaging region of HIV type 1. Bull. Math. Biol. 2003, 65, 991-1002.
61. Marrero Ponce, Y.; Castillo Garit, J.A.; Nodarse, D. Linear indices of the 'macromolecular graph's nucleotides adjacency matrix' as a promising approach for bioinformatics studies. Part 1: prediction of paromomycin's affinity constant with HIV-1 psi-RNA packaging region. Bioorg. Med. Chem. 2005, 13, 3397-3404.
62. Marrero-Ponce, Y.; Nodarse, D.; González-Díaz, H.; Ramos de Armas, R.; Romero-Zaldivar, V.; Torrens, F.; Castro, E.A. Nucleic acid quadratic indices of the "macromolecular graph's nucleotides adjacency matrix". Modeling of footprints after the interaction of Paromomycin with the HIV-1, Ψ-RNA packaging region. Int. J. Mol. Sci. 2004, 5, 276-293.
63. Bentwich, I. Prediction and validation of microRNAs and their targets. FEBS Lett. 2005, 579, 5904-5910.
64. Chou, K.C. Prediction of protein subcellular locations by incorporating quasi-sequence-order effect. Biochem. Biophys. Res. Commun. 2000, 278, 477-483.
65. Cai, Y.D.; Liu, X.J.; Xu, X.B.; Chou, K.C. Support vector machines for prediction of protein subcellular location by incorporating quasi-sequence-order effect. J. Cell. Biochem. 2002, 84, 343-348.
66. Shen, H.; Chou, K.C. Using optimized evidence-theoretic K-nearest neighbor classifier and pseudo-amino acid composition to predict membrane protein types. Biochem. Biophys. Res. Commun. 2005, 334, 288-292.
67. Liu, H.; Yang, J.; Wang, M.; Xue, L.; Chou, K.C. Using fourier spectrum analysis and pseudo amino acid composition for prediction of membrane protein types. Protein J. 2005, 24, 385-389.
68. Cai, Y.D.; Lin, S.L. Support vector machines for predicting rRNA-, RNA-, and DNA-binding proteins from amino acid sequence. Biochim. Biophys. Acta 2003, 1648, 127-133.
69. Cai, Y.D.; Chou, K.C. Using functional domain composition to predict enzyme family classes. J. Proteome Res. 2005, 4, 109-111.
70. Cai, Y.D.; Zhou, G.P.; Chou, K.C. Predicting enzyme family classes by hybridizing gene product composition and pseudo-amino acid composition. J. Theor. Biol. 2005, 234, 145-149.
71. Chou, K.C. Using amphiphilic pseudo amino acid composition to predict enzyme subfamily classes. Bioinformatics 2005, 21, 10-19.
72. Chou, K.C.; Cai, Y.D. Predicting protein quaternary structure by pseudo amino acid composition. Proteins 2003, 53, 282-289.
73. Ramos de Armas, R.; Gonzalez-Diaz, H.; Molina, R.; Perez Gonzalez, M.; Uriarte, E. Stochastic-based descriptors studying peptides biological properties: modeling the bitter tasting threshold of dipeptides. Bioorg. Med. Chem. 2004, 12, 4815-4822.
74. Moreau, G.; Broto, P. Autocorrelation of a topological structure: A new molecular descriptor. Nouv. J. Chim. 1980, 4, 359-360.
75. Tashiro, M.; Tejero, R.; Zimmerman, D.E.; Celda, B.; Nilsson, B.; Montelione, G.T. High-resolution solution NMR structure of the Z domain of staphylococcal protein A. J. Mol. Biol. 1997, 272, 573-590.
76. Navarro, E.; Tejero, R.; Fenude, E.; Celda, B. Solution NMR structure of a D,L-alternating oligonorleucine as a model of beta-helix. Biopolymers 2001, 59, 110-119.
77. Navarro, E.; Fenude, E.; Celda, B. Conformational and structural analysis of the equilibrium between single- and double-strand beta-helix of a D,L-alternating oligonorleucine. Biopolymers 2004, 73, 229-241.
78. Navarro, E.; Fenude, E.; Celda, B. Solution structure of a D,L-alternating oligonorleucine as a model of double-stranded antiparallel beta-helix. Biopolymers 2002, 64, 198-209.
79. Ramos de Armas, R.; Gonzalez-Diaz, H.; Molina, R.; Uriarte, E. Markovian Backbone Negentropies: Molecular descriptors for protein research. I. Predicting protein stability in Arc repressor mutants. Proteins 2004, 56, 715-723.
80. Gonzalez-Diaz, H.; Uriarte, E.; Ramos de Armas, R. Predicting stability of Arc repressor mutants with protein stochastic moments. Bioorg. Med. Chem. 2005, 13, 323-331.
81. Marrero-Ponce, Y.; Medina-Marrero, R.; Castillo-Garit, J.A.; Romero-Zaldivar, V.; Torrens, F.; Castro, E.A. Protein linear indices of the 'macromolecular pseudograph alpha-carbon atom adjacency matrix' in bioinformatics. Part 1: prediction of protein stability effects of a complete set of alanine substitutions in Arc repressor. Bioorg. Med. Chem. 2005, 13, 3003-3015.
82. Marrero-Ponce, Y.; Medina-Marrero, R.; Castro, A.E.; Ramos de Armass, R.; González-Díaz, H.; Romero-Zaldivar, V.; Torrens, F. Protein quadratic indices of the "macromolecular pseudograph's α-carbon atom adjacency matrix". 1. Prediction of Arc repressor Alanine-mutant's stability. Molecules 2004, 9, 1124-1147.
83. Gonzalez-Diaz, H.; Uriarte, E. Proteins QSAR with Markov average electrostatic potentials. Bioorg. Med. Chem. Lett. 2005, 15, 5088-5094.
84. Gonzalez-Diaz, H.; Sanchez-Gonzalez, A.; Gonzalez-Diaz, Y. 3D-QSAR study for DNA cleavage proteins with a potential anti-tumor ATCUN-like motif. J. Inorg. Biochem. 2006, 100, 1290-1297.
85. Saiz-Urra, L.; Gonzalez-Diaz, H.; Uriarte, E. Proteins Markovian 3D-QSAR with spherically-truncated average electrostatic potentials. Bioorg. Med. Chem. 2005, 13, 3641-3647.
86. Gonzalez-Diaz, H.; Molina, R.; Uriarte, E. Recognition of stable protein mutants with 3D stochastic average electrostatic potentials. FEBS Lett. 2005, 579, 4297-4301.
87. Gupta, N.; Mangal, N.; Biswas, S. Evolution and similarity evaluation of protein structures in contact map space. Proteins 2005, 59, 196-204.
88. Vullo, A.; Frasconi, P. Prediction of protein coarse contact maps. J. Bioinform. Comput. Biol. 2003, 1, 411-431.
89. Chapman, M.S. Mapping the surface properties of macromolecules. Protein Sci. 1993, 2, 459-469.
90. Chapman, M.S.; Rossmann, M.G. Comparison of surface properties of picornaviruses: strategies for hiding the receptor site from immune surveillance. Virology 1993, 195, 745-756.
91. Vlasak, M.; Blomqvist, S.; Hovi, T.; Hewat, E.; Blaas, D. Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination. J. Virol. 2003, 77, 6923-6930.
92. González-Díaz, H.; Molina, R.; Uriarte, E. Stochastic molecular descriptors for polymers. 1. Modelling the properties of icosahedral viruses with 3D-Markovian negentropies. Polymer 2084, 45, 3845-3853.
93. González-Díaz, H.; Uriarte, E. Biopolymer stochastic moments. I. Modeling Human Rhinovirus cellular recognition with protein surface electrostatic moments. Biopolymer 2005, 77, 296-303.
94. Rossmann, M.G. Viral cell recognition and entry. Protein Sci. 1994, 3, 1712-1725.
95. Suzuki, T.; Yamaya, M.; Kamanaka, M.; Jia, Y.X.; Nakayama, K.; Hosoda, M.; Yamada, N.; Nishimura, H.; Sekizawa, K.; Sasaki, H. Type 2 rhinovirus infection of cultured human tracheal epithelial cells: role of LDL receptor. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280, L409-L420.
96. Xing, L.; Casasnovas, J.M.; Cheng, R.H. Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating. J. Virol. 2003, 77, 6101-6107.
97. Gan, H.H.; Pasquali, S.; Schlick, T. Exploring the repertoire of RNA secondary motifs using graph theory; implications for RNA design. Nucleic Acids Res. 2003, 31, 2926-2943.
98. Zuker, M.; Jacobson, A.B. "Well-determined" regions in RNA secondary structure prediction: analysis of small subunit ribosomal RNA. Nucleic Acids Res. 1995, 23, 2791-2798.
99. Mathews, D.H.; Turner, D.H. Dynalign: an algorithm for finding the secondary structure common to two RNA sequences. J. Mol. Biol. 2002, 317, 191-203.
100. Mathews, D.H. Revolutions in RNA secondary structure prediction. J. Mol. Biol. 2006, 359, 526-532.
101. González-Díaz, H.; Pérez-Bello, A.; Uriarte, E. Stochastic molecular descriptors for polymers. 3. Markov electrostatic moments as polymer 2D-folding descriptors: RNA-QSAR for mycobacterial promoters. Polymers 2005, 46, 6461-6473.
102. Gonzalez-Diaz, H.; Perez-Bello, A.; Uriarte, E.; Gonzalez-Diaz, Y. QSAR study for mycobacterial promoters with low sequence homology. Bioorg. Med. Chem. Lett. 2006, 16, 547-553.
103. Kalate, R.N.; Tambe, S.S.; Kulkarni, B.D. Artificial neural networks for prediction of mycobacterial promoter sequences. Comput. Biol. Chem. 2003, 27, 555-564.
104. Gates, M.A. A simple way to look at DNA. J. Theor. Biol. 1986, 119, 319-328.
105. Leong, P.M.; Mogenthaler, S. Random walk and gap plots of DNA sequences. Comput. Appl. Biosci. 1995, 11, 503-507.
106. Nandy, A. Two-dimensional graphical representation of DNA sequences and intron-exon discrimination in intron-rich sequences. Comput. Appl. Biosci. 1996, 12, 55-62.
107. Nandy, A. Recent investigations into global characteristics of long DNA sequences. Indian J. Biochem. Biophys. 1994, 31, 149-155.
108. Randić, M.; Vracko, M. On the similarity of DNA primary sequences. J. Chem. Inf. Comput. Sci. 2000, 40, 599-606.
109. Randić, M.; Condensed representation of DNA primary sequences. J. Chem. Inf. Comput. Sci. 2000, 40, 50-56.
110. Liao, B.; Ding, K. Graphical approach to analyzing DNA sequences. J. Comput. Chem. 2005, 26, 1519-1523.
111. Liao, B.; Wang, T.M. Analysis of similarity/dissimilarity of DNA sequences based on nonoverlapping triplets of nucleotide bases. J. Chem. Inf. Comput. Sci. 2004, 44, 1666-1670.
112. Liao, B.; Wang, T.M. New 2D graphical representation of DNA sequences. J. Comput Chem. 2004, 25, 1364-1368.
113. Liu, Y.; Guo, X.; Xu, J.; Pan, L.; Wang, S. Some notes on 2-D graphical representation of DNA sequence. J. Chem. Inf. Comput. Sci. 2002, 42, 529-533.
114. Randić, M.; Vračko, M.; Nandy, A.; Basak S.C. On 3-D graphical representation of DNA primary sequences and their numerical characterization. J. Chem. Inf. Comput. Sci. 2000, 40, 1235-1244.
115. Randić, M.; Balaban, A.T. On a four-dimensional representation of DNA primary sequences. J. Chem. Inf. Comput. Sci. 2003, 43, 532-539.
116. Zupan, J.; Randić, M. Algorithm for coding DNA sequences into "spectrum-like" and "zigzag" representations. J. Chem. Inf. Model. 2005, 45, 309-313.
117. Randić, M. Graphical representations of DNA as 2-D map. Chem. Phys. Lett. 2004, 386, 468-471.
118. Gaboriaud, C.; Bissery, V.; Benchetrit, T.; Mornon, J.P. Hydrophobic cluster analysis: an efficient new way to compare and analyse amino acid sequences. FEBS Lett. 1997, 224, 149-155.
119. Aguero-Chapin, G.; Gonzalez-Diaz, H.; Molina, R.; Varona-Santos, J.; Uriarte, E.; Gonzalez-Diaz, Y. Novel 2D maps and coupling numbers for protein sequences. The first QSAR study of polygalacturonases; isolation and prediction of a novel sequence from Psidium guajava L. FEBS Lett. 2006, 580, 723-730.
120. Wolf, Y.I.; Carmel, L.; Koonin, E.V. Unifying measures of gene function and evolution. Proc. Biol. Sci. 2006, 273, 1507-1515.
121. Salwinski, L.; Miller, C.S.; Smith, A.J.; Pettit, F.K.; Bowie, J.U.; Eisenberg, D. The database of interacting proteins: 2004 update. Nucleic Acids Res. 2004, 32, D449-D451.
122. Vazquez, A.; Flammini A.; Maritan, A.; Vespignani A. Global protein function prediction from protein-protein interaction networks. Nat. Biotechnol. 2003, 21, 697-700.
123. Jeong, H.; Mason, S.P.; Barabási, A.-L.; Oltvai, Z.N. Lethality and centrality in protein networks. Nature 2001, 411, 41-42.
124. Manke, T.; Demetrius, L.; Vingron, M. Lethality and entropy of protein interaction networks. Genome Inform. Ser. 2005, 16, 159-163.
125. Estrada, E. Virtual identification of essential proteins within the protein interaction network of yeast. Proteomics 2006, 6, 35-40.
126. Junker, B.H.; Koschuetzki, D.; Schreiber, F. Exploration of biological network centralities with CentiBiN. BMC Bioinformatics 2006, 7, 219.
127. Shimbel, A. Structural parameters of communication networks. Bull. Math. Biophys. 1953, 15, 501-507.
128. Freeman, L.C. A set of measures of centrality based upon betweenness. Sociometry 1977, 40, 35-41.
129. Sabidussi, G. The centrality index of a graph. Psychometrika 1966, 31, 581-603.
130. Harary, F.; Hage, P. Eccentricity and centrality in networks. Social Networks 1995, 17, 57-63.
131. Marengo, E.; Leardi, R.; Robotti, E.; Righetti, P.G.; Antonucci, F.; Cecconi, D. Application of three-way principal component analysis to the evaluation of two-dimensional maps in proteomics. J. Proteome Res. 2003, 2, 351-360.
132. Marengo, E.; Robotti, E.; Gianotti, V.; Righetti, P.G.; Cecconi, D.; Domenici E. A new integrated statistical approach to the diagnostic use of two-dimensional maps. Electrophoresis 2003, 24, 225-236.
133. Randić, M. A graph theoretical characterization of proteomics maps. Int. J. Quant. Chem. 2002, 90, 848-858.
134. Bajzer, Z.; Randić, M.; Plavšic, D.; Basak, S.C. Novel map descriptors for characterization of toxic effects in proteomics maps. J. Mol. Graph. Model. 2003, 22, 1-9.